Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives

Detalles Bibliográficos
Autores principales: Sriwijitalai, Won, Wiwanitkit, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2019
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373499/
https://www.ncbi.nlm.nih.gov/pubmed/30468431
http://dx.doi.org/10.4274/tjh.galenos.2018.2018.0397
_version_ 1783395000270192640
author Sriwijitalai, Won
Wiwanitkit, Viroj
author_facet Sriwijitalai, Won
Wiwanitkit, Viroj
author_sort Sriwijitalai, Won
collection PubMed
description
format Online
Article
Text
id pubmed-6373499
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-63734992019-03-01 Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives Sriwijitalai, Won Wiwanitkit, Viroj Turk J Haematol Letters to the Editor Galenos Publishing 2019-03 2019-02-07 /pmc/articles/PMC6373499/ /pubmed/30468431 http://dx.doi.org/10.4274/tjh.galenos.2018.2018.0397 Text en © Copyright 2019 by Turkish Society of Hematology / Turkish Journal of Hematology, Published by Galenos Publishing House. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Sriwijitalai, Won
Wiwanitkit, Viroj
Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives
title Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives
title_full Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives
title_fullStr Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives
title_full_unstemmed Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives
title_short Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives
title_sort bendamustine and rituximab treatment, chronic lymphocytic leukemia, direct antiglobulin test, and false negatives
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373499/
https://www.ncbi.nlm.nih.gov/pubmed/30468431
http://dx.doi.org/10.4274/tjh.galenos.2018.2018.0397
work_keys_str_mv AT sriwijitalaiwon bendamustineandrituximabtreatmentchroniclymphocyticleukemiadirectantiglobulintestandfalsenegatives
AT wiwanitkitviroj bendamustineandrituximabtreatmentchroniclymphocyticleukemiadirectantiglobulintestandfalsenegatives

Ejemplares similares